(PharmaNewsWire.Com, December 21, 2017 ) According to the report Latin America Anti-venom Market, published by Market Data Forecast, the global market is projected to reach USD 160.6 million by 2021, at a CAGR of 7.42% from 2016 to 2021.
Bites that are venomous in nature may lead to excess saliva production in the mouth, muscle soreness, difficulty in breathing, and other issues that in turn might result in death of the victim. The estimated number of people affected with snake bites annually in Latin America is very large. To beat the serious after-effects of venomous bites, the pharmaceutical sector has come up with many Anti-venom products like vaccines and hyper immune sera.
Latin America Anti-venom Market: Drivers & Restraints Growing number of snake bite control centres, easier Anti-venom products sanctioning, development in research activities to support the efficiency of Anti-venom products, increasing clinical trials for Anti-venom products study are responsible for the growth of Latin America Anti-venom market. Also, increasing awareness and fear amongst the people regarding snake bites, and prevalence of highly developed medical care are fuelling the growth of Latin America Anti-venom Market. However, strict regulations for product approval and high cost of manufacturing these products are estimated to restrict the growth of Latin America Anti-venom Market.
Latin America Anti-venom market: Overview Latin America Anti-venom market is expected to witness high demand because of increased incidences of snake bites all over the continent, estimated to be about 4000-7000 in number.
Latin America Anti-venom market: Region-wise Outlook The Latin America Anti-venom market is analysed under various regions namely Mexico, Brazil and Argentina. With increased focus on R & D as well as with the developing economy, these countries are expected to show a lot of scope for the growth of Anti-venom market in Latin America.
Key Questions Answered What is the current and future Latin America Anti-venom market outlook in worldwide? What trends are affecting the market? What is the competitive landscape and market share of major players in the Latin America Anti-venom market? What are the key, high growth markets that Latin America Anti-venom manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Latin America Anti-venom market? How will emerging technologies fulfil these unmet needs? What is physician perception and market outlook of Latin America Anti-venom market? What are the challenges and barriers that have hindered widespread adoption of Anti-venom in Latin America?
Latin America Anti-venom market: Key Players Key market players in the Anti-venom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
Reasons to buy Latin America Anti-venom market Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of type and animals with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceutical Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
